ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

March 9, 2007

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

Zwelling Moves to Legacy Community Health

July 19, 2013

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Corrections Made To NCI Phone Directory

May 17, 1991

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989